Carregant...
The oncolytic peptide LTX-315 triggers necrotic cell death
The oncolytic peptide LTX-315 has been designed for killing human cancer cells and turned out to stimulate anti-cancer immune responses when locally injected into tumors established in immunocompetent mice. Here, we investigated the question whether LTX-315 induces apoptosis or necrosis. Transmissio...
Guardat en:
| Publicat a: | Cell Cycle |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825625/ https://ncbi.nlm.nih.gov/pubmed/26566869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2015.1093710 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|